Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | KIT |
| Variant | C443S |
| Impact List | missense |
| Protein Effect | unknown |
| Gene Variant Descriptions | KIT C443S lies within Ig-like C2-type domain 5 of the Kit protein (UniProt.org). C443S has been identified in the scientific literature (PMID: 25003536), but has not been biochemically characterized and therefore, its effect on Kit protein function is unknown (PubMed, Nov 2025). |
| Associated Drug Resistance | |
| Category Variants Paths |
KIT mutant KIT exon8 KIT C443S |
| Transcript | NM_000222.3 |
| gDNA | chr4:g.54723679T>A |
| cDNA | c.1327T>A |
| Protein | p.C443S |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_001385286.1 | chr4:g.54723679T>A | c.1327T>A | p.C443S | RefSeq | GRCh38/hg38 |
| NM_001385285.1 | chr4:g.54723679T>A | c.1327T>A | p.C443S | RefSeq | GRCh38/hg38 |
| XM_017008180 | chr4:g.54723679T>A | c.1327T>A | p.C443S | RefSeq | GRCh38/hg38 |
| XM_017008178 | chr4:g.54723679T>A | c.1327T>A | p.C443S | RefSeq | GRCh38/hg38 |
| XM_017008180.1 | chr4:g.54723679T>A | c.1327T>A | p.C443S | RefSeq | GRCh38/hg38 |
| NM_000222.2 | chr4:g.54723679T>A | c.1327T>A | p.C443S | RefSeq | GRCh38/hg38 |
| NM_001093772 | chr4:g.54723679T>A | c.1327T>A | p.C443S | RefSeq | GRCh38/hg38 |
| NM_001093772.2 | chr4:g.54723679T>A | c.1327T>A | p.C443S | RefSeq | GRCh38/hg38 |
| NM_000222 | chr4:g.54723679T>A | c.1327T>A | p.C443S | RefSeq | GRCh38/hg38 |
| NM_001093772.1 | chr4:g.54723679T>A | c.1327T>A | p.C443S | RefSeq | GRCh38/hg38 |
| XM_017008178.1 | chr4:g.54723679T>A | c.1327T>A | p.C443S | RefSeq | GRCh38/hg38 |
| NM_000222.3 | chr4:g.54723679T>A | c.1327T>A | p.C443S | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| KIT C443S | mucosal melanoma | sensitive | Imatinib | Case Reports/Case Series | Actionable | In a clinical case study, a patient with mucosal melanoma harboring KIT C443S demonstrated a substantial response to Gleevec (imatinib) in the first two weeks and then developed progression at 15 weeks (PMID: 25003536). | 25003536 |